ZYNTESA Trademark

Trademark Overview

On Saturday, June 19, 2010, a trademark application was filed for ZYNTESA with the United States Patent and Trademark Office. The USPTO has given the ZYNTESA trademark a serial number of 79087256. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, June 19, 2020. This trademark is owned by Affymax Pharma Limited. The ZYNTESA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; * excluding ophthalmic pharmaceutical preparations *
zyntesa

General Information

Serial Number79087256
Word MarkZYNTESA
Filing DateSaturday, June 19, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, June 19, 2020
Registration Number4000602
Registration DateTuesday, July 26, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2010

Trademark Statements

Certificate of Correction for RegistrationThe following "excluding ophthalmic pharmaceutical preparations" should be inserted at the end of class 5.
Goods and ServicesPharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; * excluding ophthalmic pharmaceutical preparations *

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffymax Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB
Party NameAffymax Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB
Party NameAffymax Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB

Trademark Events

Event DateEvent Description
Saturday, July 10, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, July 10, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 15, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, November 20, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, November 20, 2018INVALIDATION PROCESSED
Friday, November 2, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 2, 2018CANCELLED SECTION 71
Thursday, August 4, 2016NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 26, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 18, 2013INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, July 17, 2012PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 6, 2012NOTIFICATION PROCESSED BY IB
Friday, October 21, 2011FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 21, 2011FINAL DISPOSITION PROCESSED
Monday, October 17, 2011CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, October 17, 2011ASSIGNED TO PARALEGAL
Monday, October 17, 2011LIMITATION FROM THE IB EXAMINED AND ENTERED
Saturday, October 8, 2011LIMITATION OF GOODS RECEIVED FROM IB
Thursday, August 25, 2011GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 26, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2011EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, December 22, 2010EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 7, 2010PUBLISHED FOR OPPOSITION
Thursday, December 2, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 17, 2010NOTICE OF PUBLICATION
Wednesday, November 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 3, 2010ASSIGNED TO LIE
Wednesday, October 20, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 19, 2010APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2010ASSIGNED TO EXAMINER
Friday, October 15, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 14, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zyntesa induced degeneration failure pharmaceuticals cellular anoxia renal hypoxia preparations pharmaceutical